Yiheng Capital Management, L.P.

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1447228 SAN FRANCISCO, CA

Position in KYMR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,274,664

+$1,157,847 QoQ

Shares Held

63,440

-13.6% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

3.20%

of 13F equity value

Holder Rank

#83

of 275 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Yiheng Capital Management, L.P. holds $18,566,712 across 5 Biotechnology names. KYMR ranks #2 (39.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRDN	Viridian Therapeutics, Inc.\DE	400,464	$7,356,523
2	KYMR	Kymera Therapeutics, Inc. This page	63,440	$7,274,664
3	DBVT	DBV Technologies S.A.	170,142	$2,790,328
4	BEAM	Beam Therapeutics Inc.	21,126	$725,044
5	PASG	Passage BIO, Inc.	86,097	$420,153

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,274,664	63,440	-13.6%	Shares	Sole	2026-08-14
2026-03-31	$6,116,817	73,440	0.0%	Shares	Sole	2026-05-15
2025-12-31	$5,714,366	73,440	-40.1%	Shares	Sole	2026-02-17
2025-09-30	$6,939,443	122,605	0.0%	Shares	Sole	2025-11-14
2025-06-30	$5,350,482	122,605	0.0%	Shares	Sole	2025-08-14
2025-03-31	$3,355,698	122,605	—	Shares	Sole	2025-05-16
No filing history on record for this holder in this stock.